A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening is a research paper published in Laboratory Investigation (2021). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIBIB NIH HHS
Grant: R21 EB029677
NCI NIH HHS
Grant: F99 CA253759
NCI NIH HHS
Grant: R01 CA215483
NCI NIH HHS
Grant: P50 CA228991
NICHD NIH HHS
Grant: R01 HD096147
NIH HHS
Grant: S10 OD025193
National Institutes of Health
Grant: 5P50CA228991-02
SPORE in Ovarian Cancer
National Institutes of Health
Grant: 1S10OD025193-01A1
Acquisition of a Cyfuse Regenova 3D Bio-printer
National Institutes of Health
Grant: 5R01CA215483-05
Experimental Therapeutics by targeting Spleen Tyrosine Kinase
National Institutes of Health
Grant: 5F99CA253759-02
Engineered Fibroblasts as Cell Therapy to Treat Colorectal Cancer via Tumor Stroma Stabilization
National Institutes of Health
Grant: 5R01HD096147-05
Role of cancer-associated mutations in endometriosis
National Institutes of Health
Grant: 1R21EB029677-01
Tension-Sensitive Drug Release System to Enhance Targeting Selectivity
Ovarian Cancer Research Fund Alliance
FWCI
1.26
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of ARID1A loss activates MAPK signaling via DUSP4 downregulation
Additional file 1 of ARID1A loss activates MAPK signaling via DUSP4 downregulation